Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Michele Fox to Graft vs Host Disease

This is a "connection" page, showing publications Michele Fox has written about Graft vs Host Disease.

 
Connection Strength
  
 
 
0.552
  
  1. Przepiorka D, Phillips GL, Ratanatharathorn V, Cottler-Fox M, Sehn LH, Antin JH, LeBherz D, Awwad M, Hope J, McClain JB. A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease. Blood. 1998 Dec 01; 92(11):4066-71.
    View in: PubMed
    Score: 0.080
  2. Barrett AJ, Mavroudis D, Tisdale J, Molldrem J, Clave E, Dunbar C, Cottler-Fox M, Phang S, Carter C, Okunnieff P, Young NS, Read EJ. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Bone Marrow Transplant. 1998 Mar; 21(6):543-51.
    View in: PubMed
    Score: 0.076
  3. Pickle LW, Cottler-Fox M. Statistical methods for the analysis of repeated measurements of serum immunoglobulin levels. Semin Hematol. 1992 Jul; 29(3 Suppl 2):116-22.
    View in: PubMed
    Score: 0.051
  4. Fassas AB, Buddharaju LN, Rapoport A, Cottler-Fox M, Drachenberg C, Meisenberg B, Tricot G. Fatal disseminated adenoviral infection associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation. Leuk Lymphoma. 2001 Aug; 42(4):801-4.
    View in: PubMed
    Score: 0.048
  5. Deeg HJ, Spitzer TR, Cottler-Fox M, Cahill R, Pickle LW. Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis. Bone Marrow Transplant. 1991 Mar; 7(3):193-8.
    View in: PubMed
    Score: 0.047
  6. Spitzer TR, Cahill R, Cottler-Fox M, Treat J, Sacher R, Deeg HJ. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature. Cancer. 1990 Dec 01; 66(11):2346-9.
    View in: PubMed
    Score: 0.046
  7. Fassas AB, Rapoport AP, Cottler-Fox M, Chen T, Tricot G. Encouraging preliminary results in 12 patients with high-risk haematological malignancies by omitting graft-versus-host disease prophylaxis after allogeneic transplantation. Br J Haematol. 2000 Nov; 111(2):662-7.
    View in: PubMed
    Score: 0.046
  8. Greenspan A, Deeg HJ, Cottler-Fox M, Sirdofski M, Spitzer TR, Kattah J. Incapacitating peripheral neuropathy as a manifestation of chronic graft-versus-host disease. Bone Marrow Transplant. 1990 May; 5(5):349-52.
    View in: PubMed
    Score: 0.044
  9. Sarkodee-Adoo C, Sotirescu D, Sensenbrenner L, Rapoport AP, Cottler-Fox M, Tricot G, Ruehle K, Meisenberg B. Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion. 2003 Jan; 43(1):78-84.
    View in: PubMed
    Score: 0.027
  10. Badros A, Tricot G, Toor A, Morris C, Guo C, Munshi N, Barlogie B, Cottler-Fox M. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion. 2002 Feb; 42(2):205-9.
    View in: PubMed
    Score: 0.025
  11. Lee CK, Badros A, Barlogie B, Morris C, Zangari M, Fassas A, van Rhee F, Cottler-Fox M, Jacobson J, Thertulien R, Muwalla F, Mazher S, Anaissie E, Tricot G. Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning. Exp Hematol. 2003 Jan; 31(1):73-80.
    View in: PubMed
    Score: 0.013
  12. Spitzer TR, Cottler-Fox M, Sullivan P, Lynch M, Tefft MC, Pickle LW, Cirenza E, Cahill R, Deeg HJ, Sacher R. Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantation. Semin Hematol. 1992 Jul; 29(3 Suppl 2):123-6.
    View in: PubMed
    Score: 0.013
  13. Badros A, Barlogie B, Siegel E, Cottler-Fox M, Zangari M, Fassas A, Morris C, Anaissie E, Van Rhee F, Tricot G. Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning. J Clin Oncol. 2002 Mar 01; 20(5):1295-303.
    View in: PubMed
    Score: 0.013
  14. Cottler-Fox M, Lynch M, Pickle LW, Cahill R, Spitzer TR, Deeg HJ. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels. Bone Marrow Transplant. 1991 Jul; 8(1):27-33.
    View in: PubMed
    Score: 0.012
  15. Spitzer TR, Cottler-Fox M, Torrisi J, Cahill R, Greenspan A, Lynch M, Deeg HJ. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation. Bone Marrow Transplant. 1989 Sep; 4(5):559-65.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.